Kali Musli

Curculigo orchioides
Kali Musli (Curculigo orchioides), also known as Black Musli, is a revered Ayurvedic herb, traditionally used for its claimed adaptogenic and rejuvenating properties. It is supposedly beneficial for balancing Vata and Pitta doshas while increasing Kapha. Widely prevalent in tropical and subtropical regions of Asia, especially India and China, its roots and rhizomes are primarily utilized in traditional medicine.
PLANT FAMILY
Hypoxidaceae (Star Grass)
PARTS USED
Root, Rhizome, Tuber
AYURVEDIC ACTION
Vata ↓, Pitta ↓, Kapha ↑
ACTIVE COMPOUNDS
Curculigoside (0.1-0.2%)

What is Kali Musli?

Kali Musli, scientifically known as Curculigo orchioides, is a perennial herbaceous plant belonging to the Hypoxidaceae (Star Grass) family. Native to tropical and subtropical regions of Asia, including India and China, it is characterized by its long, linear leaves and small, yellowish flowers that emerge from the center of the plant. The plant's primary medicinal value lies in its root and rhizome, which are thick, fleshy, and dark in color, giving it the common name "black musli."

Historically, Kali Musli has been a staple in traditional medicine systems, particularly Ayurveda, where it is revered for its adaptogenic and rejuvenating properties. It thrives in moist, shaded environments and is often found in forest undergrowth. Its unique biochemical composition contributes to its diverse applications in various traditional remedies.

Other Names of Kali Musli

  • Black Musli
  • Golden Eye Grass
  • Xian Mao
  • Talamuli
  • Musli Siyah

Benefits of Kali Musli

Heading

<h3> Absolute Contraindications of Kali Musli </h3> <h4> Pregnancy & Breastfeeding (Avoid use during pregnancy and lactation)</h4> <ul> <li> 🤰</li> <li> Recommendation: Do not use Kali Musli in pregnancy or while breastfeeding unless a qualified physician has evaluated risks and benefits.</li> <li> Reasoning: Animal studies show estrogen-like/uterotrophic effects (uterine growth and vaginal cornification) after extract administration; because hormones and uterine stimulation can affect pregnancy and fetal development, safety has not been established in humans.</li> <li> Scientific_Study_Title: Evaluation of estrogenic activity of alcoholic extract of rhizomes of Curculigo orchioides.</li> <li> Scientific_Study_Authors: K. Vijayanarayana, Rashmi S. Rodrigues, K. S. Chandrashekhar, E. V. S. Subrahmanyam</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/17900835/</li> <li> Scientific_Study_Excerpt: <p>"showed a significant increase in percentage vaginal cornification" (short quoted phrase from abstract).</p> <p>Paraphrase of study findings and relevance: In ovariectomized rats the alcoholic rhizome extract produced uterotrophic changes - increased uterine weight, uterine glycogen and proliferative changes in endometrium - consistent with estrogen-like action. Such estrogenic/uterotrophic activity in animal models is a mechanistic basis to avoid use during pregnancy and lactation because hormones that alter uterine or endocrine milieu can influence fetal development and milk production. (Paraphrase based on the J Ethnopharmacol 2007 abstract.)</p> </li> </ul> <h4> Hormone-sensitive cancers (e.g., breast, uterine) or history of estrogen-driven tumours</h4> <ul> <li> 🎗️</li> <li> Recommendation: Avoid Kali Musli if you have active or recent hormone-sensitive cancer unless directed and supervised by your oncologist; do not self-prescribe for supportive use during cancer therapy.</li> <li> Reasoning: Components of C. orchioides (polysaccharides, phenolic glycosides) exert estrogen-like effects in ovariectomized animal models and improve bone by estrogenic-like mechanisms - this raises caution in hormone-sensitive malignancies.</li> <li> Scientific_Study_Title: Structural elucidation and anti-osteoporosis activities of polysaccharides obtained from Curculigo orchioides.</li> <li> Scientific_Study_Authors: Xueqian Wang, Mengliu Zhang, Dawei Zhang, Xinluan Wang, Huijuan Cao, Qian Zhang, Chunyan Yan</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/30318216/</li> <li> Scientific_Study_Excerpt: <p>"comparable to that of 17β-estradiol" (short quoted phrase from abstract).</p> <p>Paraphrase of study findings and relevance: The study reports that crude polysaccharide fractions improved bone density and markers in ovariectomized rats with activity comparable to estradiol, indicating estrogen-like biological activity at bone and possibly other estrogen-responsive tissues. For persons with hormone-sensitive cancers, agents with estrogenic effects may theoretically stimulate tumor growth; therefore use is contraindicated without specialist advice.</p> </li> </ul> <h4> Long-term, very high-dose use (risk of liver & kidney injury in animal models)</h4> <ul> <li> ⚠️</li> <li> Recommendation: Do not consume super-high doses for prolonged periods; adhere to traditional/recommended dosing and consult a clinician for long-term use monitoring (liver/kidney tests if prolonged therapy is considered).</li> <li> Reasoning: Toxicology reports note that extremely high and prolonged dosing produced liver and kidney injury in animal studies - caution against chronic overdose or unsupervised long-term supplementation.</li> <li> Scientific_Study_Title: Medicinal plants of genus Curculigo: traditional uses and a phytochemical and ethnopharmacological review.</li> <li> Scientific_Study_Authors: Yan Nie, Xin Dong, Yongjing He, Tingting Yuan, Ting Han, Khalid Rahman, Luping Qin, Qiaoyan Zhang</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/23562803/</li> <li> Scientific_Study_Excerpt: <p>"may cause injury of liver and kidney" (short quoted phrase from abstract).</p> <p>Paraphrase of study findings and relevance: The review summarizes toxicology experiments reporting that extremely high doses (reported in animal studies as very large multiples of typical clinical doses) given long-term produced signs of liver and kidney injury. This indicates potential for organ toxicity with chronic overdose; it supports avoiding very high or prolonged unsupervised intake.</p> </li> </ul> <h3> Relative Contraindications of Kali Musli </h3> <h4> Concurrent use with drugs metabolized by major CYP enzymes (possible interaction)</h4> <ul> <li> 💊</li> <li> Recommendation: If you take drugs with a narrow therapeutic index (e.g., certain statins, calcineurin inhibitors, some benzodiazepines) consult a clinician before using Kali Musli; monitoring or dose adjustment may be required.</li> <li> Reasoning: In vitro data on curculigoside (a major active constituent) indicate it can inhibit human liver cytochrome P450 enzymes in laboratory systems - this raises potential for altered blood levels of co-administered medicines metabolized by those CYPs.</li> <li> Scientific_Study_Title: Inhibitory effects of curculigoside on human liver cytochrome P450 enzymes.</li> <li> Scientific_Study_Authors: J. Lang, W. Li, J. Zhao, K. Wang, D. Chen</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/27819189/</li> <li> Scientific_Study_Excerpt: <p>"Inhibitory effects of curculigoside on human liver cytochrome P450 enzymes" (short quoted phrase from title/record).</p> <p>Paraphrase of study findings and relevance: The Xenobiotica 2017 in vitro study reports that curculigoside inhibits one or more CYP isoforms in human liver microsomes. In vitro CYP inhibition suggests a possibility of herb-drug interactions with medicines metabolized by affected CYPs; clinical significance needs direct clinical study but caution is warranted, especially with narrow-therapeutic-index drugs.</p> </li> </ul> <h4> Concurrent use with strong P-gp inhibitors or inducers (can alter curculigoside levels)</h4> <ul> <li> 🔁</li> <li> Recommendation: If you use P-glycoprotein inhibitors (e.g., verapamil) or potent inducers, discuss with a clinician first - levels of curculigoside (and therefore effect) may change.</li> <li> Reasoning: Pharmacokinetic experiments in rats show verapamil (a P-gp inhibitor) increases curculigoside plasma levels and AUC, indicating interaction at intestinal transporters that alter absorption and clearance.</li> <li> Scientific_Study_Title: The effects of verapamil on the pharmacokinetics of curculigoside in rats.</li> <li> Scientific_Study_Authors: K. Wang, J. Zhao, J. Lang</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/27328778/</li> <li> Scientific_Study_Excerpt: <p>"verapamil could significantly increase the peak plasma concentration ... and AUC of curculigoside" (short quoted fragment paraphrased from abstract).</p> <p>Paraphrase of study findings and relevance: Rat pharmacokinetic data show verapamil increased curculigoside absorption and exposure, implicating P-glycoprotein in curculigoside transport. This supports caution when combining Kali Musli or curculigoside with medications that affect P-gp or relevant transporters because herbal exposure (and effects or side effects) may be altered.</p> </li> </ul>

Heading

<h4> Liver or kidney injury with prolonged, very high-dose use</h4> <ul> <li> 🏥</li> <li> Side effect summary: Animal studies have reported liver and kidney damage after prolonged administration of very large doses - this is mainly a risk with chronic overdose rather than short-term, standard dosing.</li> <li> Recommendation: Use recommended doses only; for long-term therapy ask a clinician and monitor liver and kidney tests if advised. Stop and seek medical care if you notice jaundice, persistent abdominal pain, dark urine, swelling or reduced urine output.</li> <li> Reasoning: Reviews and toxicity studies summarize that extreme long-term dosing caused biochemical and histological signs of organ injury in animals, indicating potential accumulation or toxicity at very high exposure.</li> <li> Severity Level: Severe</li> <li> Scientific_Study_Available: Yes</li> <li> Scientific_Study_Title: Medicinal plants of genus Curculigo: traditional uses and a phytochemical and ethnopharmacological review.</li> <li> Scientific_Study_Authors: Yan Nie, Xin Dong, Yongjing He, Tingting Yuan, Ting Han, Khalid Rahman, Luping Qin, Qiaoyan Zhang</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/23562803/</li> <li> Scientific_Study_Excerpt: <p>"may cause injury of liver and kidney" (short quoted phrase from abstract).</p> <p>Paraphrase of study findings and relevance: The review notes toxicology experiments in which very large doses administered long-term (far exceeding recommended clinical doses) produced evidence of hepatic and renal injury in animal models. This outlines a credible safety concern for chronic overdose and supports monitoring and conservative dosing in humans.</p> </li> </ul> <h4> Uterine stimulation / estrogen-like effects (may influence menstrual or hormone-driven conditions)</h4> <ul> <li> ⚠️</li> <li> Side effect summary: In animal models Kali Musli extracts produced uterine growth and hormonal-like changes; in susceptible people this could influence menstrual bleeding patterns or hormone-sensitive conditions.</li> <li> Recommendation: If you have abnormal uterine bleeding, fibroids, endometriosis, or are taking hormone therapy, consult your healthcare provider before using Kali Musli.</li> <li> Reasoning: Uterotrophic assays and ovariectomized animal studies demonstrate estrogenic endpoints (uterine weight, vaginal cornification), giving mechanistic reason to expect estrogenic activity in biological systems.</li> <li> Severity Level: Moderate</li> <li> Scientific_Study_Available: Yes</li> <li> Scientific_Study_Title: Evaluation of estrogenic activity of alcoholic extract of rhizomes of Curculigo orchioides.</li> <li> Scientific_Study_Authors: K. Vijayanarayana, Rashmi S. Rodrigues, K. S. Chandrashekhar, E. V. S. Subrahmanyam</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/17900835/</li> <li> Scientific_Study_Excerpt: <p>"significant increase in percentage vaginal cornification" (short quoted phrase from abstract).</p> <p>Paraphrase of study findings and relevance: The 2007 J Ethnopharmacol study reported uterotrophic and estrogen-like markers in ovariectomized rats treated with alcoholic extract, supporting the possibility of estrogenic effects in biological systems and potential perturbation of hormone-sensitive physiology in humans.</p> </li> </ul>

Heading

<h4> Drugs metabolized by CYP3A4 (e.g., some statins, calcium-channel blockers, certain immunosuppressants)</h4> <ul> <li> Interaction_Details: In vitro data indicate curculigoside (a major active) can inhibit human liver CYP enzymes; inhibition of CYP3A4 could raise blood levels of drugs primarily cleared by CYP3A4, increasing effect or toxicity.</li> <li> Severity: Moderate</li> <li> Recommendation: Consult your clinician before combining Kali Musli with drugs that are primarily CYP3A4 substrates and have narrow therapeutic windows (e.g., tacrolimus, cyclosporine, some statins). Monitoring drug levels or choosing alternatives may be necessary.</li> <li> Scientific_Study_Available: Yes</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/27819189/</li> <li> Scientific_Study_Title: Inhibitory effects of curculigoside on human liver cytochrome P450 enzymes.</li> <li> Scientfic_Study_Authors: J. Lang, W. Li, J. Zhao, K. Wang, D. Chen</li> <li> Scientific_Study_Excerpt: <p>"Inhibitory effects of curculigoside on human liver cytochrome P450 enzymes" (short quoted phrase from title/record).</p> <p>Paraphrase of study findings and relevance: The Xenobiotica 2017 in vitro experiments report curculigoside can inhibit activities of human liver CYP isoforms in microsomal systems. While in vitro inhibition does not always translate into clinically significant interactions, it provides a mechanistic basis for potential interactions with CYP3A4 substrates and supports clinical caution and monitoring when coadministered.</p> </li> </ul> <h4> P-glycoprotein (P-gp) inhibitors / transport-modifying drugs (example: verapamil)</h4> <ul> <li> Interaction_Details: Rat pharmacokinetic studies show verapamil (a P-gp inhibitor) increases curculigoside plasma concentrations and area under the curve - indicating curculigoside is subject to transporter-mediated efflux and its levels can be altered by P-gp inhibitors.</li> <li> Severity: Moderate</li> <li> Recommendation: Avoid combining Kali Musli with strong P-gp inhibitors without clinician oversight; dose adjustments or monitoring may be needed because herb exposure (and therefore benefit or side effects) could rise.</li> <li> Scientific_Study_Available: Yes</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/27328778/</li> <li> Scientific_Study_Title: The effects of verapamil on the pharmacokinetics of curculigoside in rats.</li> <li> Scientfic_Study_Authors: K. Wang, J. Zhao, J. Lang</li> <li> Scientific_Study_Excerpt: <p>"verapamil could significantly increase the peak plasma concentration ... and AUC of curculigoside" (short quoted fragment paraphrased from abstract).</p> <p>Paraphrase of study findings and relevance: The rat study showed verapamil inhibited curculigoside efflux in intestinal cells (Caco-2 model) and decreased its clearance in microsomal assays, leading to increased systemic exposure. This supports a clinically relevant interaction potential with drugs that affect P-gp or intestinal transport.</p> </li> </ul> <h4> Hormone therapies / SERMs / exogenous estrogens</h4> <ul> <li> Interaction_Details: Because Kali Musli shows estrogen-like effects in animal models, it could theoretically modulate or interfere with hormonal therapies, contraceptives, or selective estrogen receptor modulators (SERMs).</li> <li> Severity: Mild</li> <li> Recommendation: People on hormonal therapies or contraceptives should consult their prescriber before adding Kali Musli; alternative approaches or monitoring may be advised.</li> <li> Scientific_Study_Available: Yes</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/17900835/</li> <li> Scientific_Study_Title: Evaluation of estrogenic activity of alcoholic extract of rhizomes of Curculigo orchioides.</li> <li> Scientfic_Study_Authors: K. Vijayanarayana, Rashmi S. Rodrigues, K. S. Chandrashekhar, E. V. S. Subrahmanyam</li> <li> Scientific_Study_Excerpt: <p>"significant increase in percentage vaginal cornification" (short quoted phrase from abstract).</p> <p>Paraphrase of study findings and relevance: The 2007 animal uterotrophic study demonstrated estrogenic endpoints; therefore coadministration with hormone therapies could alter net hormonal effects. This is a mechanistic rationale to discuss combined use with prescribing clinicians.</p> </li> </ul>